Publicaciones en las que colabora con Silvia Pérez Silanes (55)

2014

  1. Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents

    Molecules, Vol. 19, Núm. 2, pp. 2166-2180

2013

  1. Cyclic voltammetric study of some anti-chagas-active 1,4-dioxidoquinoxalin- 2-yl ketone derivatives

    Helvetica Chimica Acta, Vol. 96, Núm. 2, pp. 217-227

  2. New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities

    Molecules, Vol. 18, Núm. 4, pp. 4718-4727

  3. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents

    European Journal of Medicinal Chemistry, Vol. 66, pp. 324-334

  4. Quinoxalinas como potenciales agentes Antimycobacterium tuberculosis: una revisión

    Revista de la Sociedad Química del Perú, Vol. 79, Núm. 3, pp. 272-285

2012

  1. Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4- phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives

    Molecules, Vol. 17, Núm. 8, pp. 9451-9461

  2. New quinoxaline derivatives as potential mt1 and mt2 receptor ligands

    Molecules, Vol. 17, Núm. 7, pp. 7737-7757

  3. Novel sulfonylurea derivatives as H 3 receptor antagonists. Preliminary SAR studies

    European Journal of Medicinal Chemistry, Vol. 52, pp. 1-13

2011

  1. 1,4-Di-N-oxide quinoxaline-2-carboxamide: Cyclic voltammetry and relationship between electrochemical behavior, structure and anti-tuberculosis activity

    Electrochimica Acta, Vol. 56, Núm. 9, pp. 3270-3275

  2. 3-trifluoromethylquinoxaline N, N′-dioxides as anti-Trypanosomatid agents. Identification of optimal anti- T. cruzi agents and mechanism of action studies

    Journal of Medicinal Chemistry, Vol. 54, Núm. 10, pp. 3624-3636

  3. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships

    Experimental Parasitology, Vol. 128, Núm. 2, pp. 97-103

  4. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 12, pp. 3699-3703

  5. New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 15, pp. 4498-4502

  6. Novel benzo[ b ]thiophene derivatives as new potential antidepressants with rapid onset of action

    Journal of Medicinal Chemistry, Vol. 54, Núm. 8, pp. 3086-3090

  7. Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis

    Infectious Disorders - Drug Targets, Vol. 11, Núm. 2, pp. 196-204

  8. Studies on log Po/w of quinoxaline di-N-oxides: A comparison of RP-HPLC experimental and predictive approaches

    Molecules, Vol. 16, Núm. 9, pp. 7893-7908

  9. Synthesis and Biological Evaluation of New Quinoxaline Derivatives as Antioxidant and Anti-Inflammatory Agents

    Chemical Biology and Drug Design, Vol. 77, Núm. 4, pp. 255-267

  10. Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives

    Experimental Parasitology, Vol. 127, Núm. 4, pp. 745-751

2010

  1. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 21, pp. 7365-7379

  2. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 7, pp. 2713-2719